Sarah Lewis
Sarepta Therapeutics (United States)(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Virus-based gene therapy research, CAR-T cell therapy research, Cardiomyopathy and Myosin Studies, Neurogenetic and Muscular Disorders Research
Most-Cited Works
- → Eteplirsen for the treatment of Duchenne muscular dystrophy(2013)778 cited
- → Dystrophin Immunity in Duchenne's Muscular Dystrophy(2010)651 cited
- → Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy(2020)377 cited
- → Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy(2010)271 cited
- → Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2D(2010)240 cited
- → A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy(2014)229 cited
- → Eteplirsen treatment for Duchenne muscular dystrophy(2018)226 cited
- → Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins(2009)214 cited
- → Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery(2013)155 cited
- → The nature of mutations induced by replication–transcription collisions(2016)145 cited